Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Multicenter Comparative Randomized Double-blind Placebo-controlled Clinical Study of Efficacy and Safety of BCD-089 in Different Dosing Regimens in Patients With Active Rheumatoid Arthritis

NCT03455842 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT03455842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03455842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Multicenter Comparative Randomized Double-blind Placebo-controlled Clinical Study of Efficacy and Safety of BCD-089 in Different Dosing Regimens in Patients With Active Rheumatoid Arthritis
Lead sponsor
Biocad
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2018
Completion date
October 22, 2019
Enrollment
105 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

seropositive ra